AngioDynamics Reports Q4 2026 Earnings and Provides Fiscal 2027 Guidance

AngioDynamics (ANGO) reported $86.6 million in total net sales for the fourth quarter of fiscal 2026, with growth driven by both Med Tech and Med Device segments. The company provided revenue guidance of $336 to $341 million for fiscal 2027, projecting a 5% to 6.5% increase compared to FY2026.

By Motley Fool Transcribing · Motley Fool · July 21, 2026, 19:27 UTC

AngioDynamics Reports Q4 2026 Earnings and Provides Fiscal 2027 Guidance

Tickers: $ANGO

Topics: financial_performance revenue_growth segment_analysis

Read the full article at Motley Fool

More World news

Lufax Reports Third Quarter 2026 Net Loss Amid Rising Credit Impairment Costs Motley Fool · November 12, 2026, 18:15 UTC
Avantor Reports Return to Organic Revenue Growth in Third Quarter 2026 Motley Fool · November 12, 2026, 18:15 UTC
MGP Ingredients Rebrands to Sempreon and Announces Strategic Shift Toward Ready-to-Drink Products Motley Fool · November 12, 2026, 18:15 UTC
ICON Reports Q3 2026 Revenue of $2 Billion and Accelerating Book-to-Bill Ratio Motley Fool · November 12, 2026, 18:15 UTC
Beachbody (BODi) Reduces Annual Revenue Breakeven to $125 Million Amid Strategic Pivot Motley Fool · November 12, 2026, 18:15 UTC
Standard Nuclear Reports $577.2 Million Contract Backlog and Targets 2027 DOE Authorization Seeking Alpha · November 12, 2026, 18:10 UTC
Nuwellis Reports Q3 2026 Revenue of $2.2 Million and Improved Operating Loss Motley Fool · November 12, 2026, 18:09 UTC
Nebius Group Reports Strong Revenue Growth Amidst Capacity Delays and Increased Capital Expenditure Motley Fool · November 12, 2026, 18:11 UTC
Pelagos Insurance Reports Q3 2026 Earnings with Increased Gross Premiums Written Motley Fool · November 12, 2026, 18:11 UTC
Sprott Physical Gold Trust USD Reports Q3 Net Income of $508.82 Million Seeking Alpha · November 12, 2026, 18:07 UTC